Sio Gene Therapies, Inc. (SIOX): Price and Financial Metrics

Sio Gene Therapies, Inc. (SIOX): $1.12

0.03 (+2.75%)

POWR Rating

Component Grades













Add SIOX to Watchlist
Sign Up

Industry: Biotech


of 453

in industry

SIOX Stock Price Chart Interactive Chart >

Price chart for SIOX

SIOX Price/Volume Stats

Current price $1.12 52-week high $3.60
Prev. close $1.09 52-week low $1.04
Day low $1.07 Volume 198,400
Day high $1.15 Avg. volume 421,813
50-day MA $1.41 Dividend yield N/A
200-day MA $2.05 Market Cap 81.70M

Sio Gene Therapies, Inc. (SIOX) Company Bio

Sio Gene Therapies, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops gene therapies that transform the treatment of serious neurodegenerative diseases. Sio Gene Therapies serves customers worldwide.

SIOX Latest News Stream

Event/Time News Detail
Loading, please wait...

SIOX Latest Social Stream

Loading social stream, please wait...

View Full SIOX Social Stream

Latest SIOX News From Around the Web

Below are the latest news stories about Sio Gene Therapies Inc that investors may wish to consider to help them evaluate SIOX as an investment opportunity.

Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ...

Cambridge, MA, based Investment company Opaleye Management Inc. (Current Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus NV, sells ESSA Pharma Inc, Seres Therapeutics Inc, CM Life Sciences Inc, Lumos Pharma Inc, Kezar Life Sciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Opaleye Management Inc..

Yahoo | December 28, 2021

My Favorite Stock For 2022: Sio Gene Therapies

I began my coverage of Sio Gene Therapies (SIOX) in September 2020 noting that the company offered an interesting risk/reward proposition, but at that time I wasn't yet convinced enough to become a shareholder. Since then I've written about the company on two more occasions and became a shareholder in...

Amit Ghate on Seeking Alpha | December 27, 2021

Sio Gene Therapies Inc. (NASDAQ:SIOX) Receives Consensus Rating of Buy from Analysts

Shares of Sio Gene Therapies Inc. (NASDAQ:SIOX) have earned a consensus rating of Buy from the seven brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average 12 month target price among brokerages []

Dakota Financial News | December 16, 2021

Sio Gene Therapies Inc. (NASDAQ: SIOX) Has Succeeded To Excite In 2021, The Stock Is Down -49.64% Year-To-Date

Sio Gene Therapies Inc. (NASDAQ:SIOX)s traded shares stood at 0.48 million during the last session, with the companys beta value hitting 1.57. At the close of trading, the stocks price was $1.40, to imply a decrease of -4.11% or -$0.06 in intraday trading. The SIOX shares 52-week high remains $4.15, putting it -196.43% down since Sio Gene Therapies Inc. (NASDAQ: SIOX) Has Succeeded To Excite In 2021, The Stock Is Down -49.64% Year-To-Date Read More »

Marketing Sentinel | December 11, 2021

New Insight On Sio Gene Therapies Inc. (SIOX)

Sio Gene Therapies Inc. (NASDAQ:SIOX) concluded the trading at $1.41 on Friday, December 03 with a fall of -5.37% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.49 and 5Y monthly beta was reading 1.75 with its price kept floating in New Insight On Sio Gene Therapies Inc. (SIOX) Read More »

Stocks Register | December 4, 2021

Read More 'SIOX' Stories Here

SIOX Price Returns

1-mo -17.04%
3-mo -41.67%
6-mo -45.10%
1-year -58.97%
3-year N/A
5-year N/A
YTD -13.18%
2021 -53.60%
2020 -45.70%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.6432 seconds.